A clinico-biochemical correlation in a Parkinsonian patient treated with levodopa and decarboxylase inhibitor (Ro 4-4602). A model study.
D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use*; D004298:Dopamine / Q000097:blood / Q000652:urine; D005069:Evaluation Studies as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D010648:Phenylacetates / Q000097:blood / Q000652:urine
D008996:Monoamine Oxidase Inhibitors; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D004298:Dopamine